What is AnaptysBio, Inc.'s investing cash flow?

AnaptysBio, Inc. (ANAB) reported investing cash flow of $34.98M in Q1 2026.

How has AnaptysBio, Inc.'s investing cash flow changed year-over-year?

AnaptysBio, Inc.'s investing cash flow increased by 135.6% year-over-year, from $14.85M to $34.98M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

AnaptysBio, Inc. ANAB Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

Eli LillyLLY

-$3.92B-16.8%

PfizerPFE

$785M-76.0%

AmgenAMGN

-$716M-60.2%

Regeneron PharmaceuticalsREGN

-$428.9M-166%

BiogenBIIB

-$209.5M-343%

Other financials

Income statement

See full

Revenue$25.6M-8.0%

Operating income-$34.6M-25.8%

Net income-$52.9M-34.5%

EPS (diluted)-$1.84-43.8%

Balance sheet

See full

Cash & equivalents$248.5M+152%

Total debt$13.6K-99.9%

Total equity$12.7M-62.5%

Total assets$329.7M-21.9%

Cash flow

See full

Operating cash flow-$25.9M-142%

CapEx$17.0K-51.4%

Free cash flow-$25.9M-142%

Valuation

See full

Market cap$1.73B+180%

Enterprise value$1.48B+176%

P/S7.4×+1.9×

Profitability

See full

Operating margin17.6%+9.6pp

Net margin-49.9%-22.6pp

FCF margin1.9%+1.0pp

Returns & leverage

See full

Return on equity-343.8%-1,012pp

Debt / equity0×-0.5×

Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AnaptysBio, Inc.'s investing cash flow?: AnaptysBio, Inc. (ANAB) reported investing cash flow of $34.98M in Q1 2026.
How has AnaptysBio, Inc.'s investing cash flow changed year-over-year?: AnaptysBio, Inc.'s investing cash flow increased by 135.6% year-over-year, from $14.85M to $34.98M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.